drugset / Trial / NCT07240220

The Mother-Daughter Project: Merck-4

NCT07240220

Not yet recruiting 2500 enrolled Indiana University
Non-randomizedSingle-groupOpen-labelPrevention

Summary

This project serves to continue a community-based initiative, known as the Kenya Mother-Daughter Cervical Cancer Eradication Project, or the Mother-Daughter Project (MDP), in the Webuye region of Western Kenya. The MDP project, since its initiation in 2018, has sought to develop a framework for the eradication of cervical cancer through effective screening of adult women and through the vaccination of female children. This project specifically aims to collect additional data on the ability for HR-HPV testing to detect premalignant lesions of the cervix, especially in HIV-infected women, to investigate and identify barriers leading to non-participation in previous MDP efforts, and to examine factors associated with the immune response to HPV vaccination among rural Kenyan girls.

Timeline

Start
2026-02-01
Primary completion
2028-08-01
Completion
2028-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gardasil 9 Vaccine

Indications